Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5

Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and in liver transplant recipients.

Murray SM. et al, (2023), Journal of hepatology

CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.

Neale I. et al, (2023), mBio

Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.

Gillespie IA. et al, (2023), Infectious diseases and therapy

Joint statement in support of hepatitis C human challenge studies.

Alter HJ. et al, (2023), The lancet. Gastroenterology & hepatology

Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history

Hornsby H. et al, (2023), Nature Communications, 14

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

Hamill V. et al, (2023), BMJ (Clinical research ed.), 382

Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.

Gillespie IA. et al, (2023), Infectious diseases and therapy

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774

Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.

Johnson SA. et al, (2023), Clinical and experimental immunology, 212, 249 - 261

An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome

Ng E. et al, (2023), Journal of General Virology, 104

Defining the key intrahepatic gene networks in HCV infection driven by sex

Marchi E. et al, (2023), Gut, 72, 984 - 994

Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.

Liao W. et al, (2023), EClinicalMedicine, 59

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

Murray SM. et al, (2023), Nature Reviews Immunology, 23, 304 - 316

Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.

Hamill V. et al, (2023), Liver international : official journal of the International Association for the Study of the Liver, 43, 917 - 927

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults

Green C. et al, (2023), Clinical and Experimental Immunology, 211, 269 - 279

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?

Campbell C. et al, (2023), Wellcome Open Research, 7, 203 - 203

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Brevini T. et al, (2023), Nature, 615, 134 - 142

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

Moore SC. et al, (2023), Med, 4, 191 - 215.e9

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?